AstraZeneca PLC Files November 2025 6-K Report

Ticker: AZN · Form: 6-K · Filed: Nov 3, 2025 · CIK: 901832

Astrazeneca PLC 6-K Filing Summary
FieldDetail
CompanyAstrazeneca PLC (AZN)
Form Type6-K
Filed DateNov 3, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: foreign-issuer, sec-filing, routine-report

Related Tickers: AZN

TL;DR

AZN filed its monthly 6-K, standard international issuer report, no major news.

AI Summary

AstraZeneca PLC filed a Form 6-K on November 3, 2025, reporting as a foreign issuer. The filing is for the month of November 2025 and indicates the company files annual reports under Form 20-F. AstraZeneca PLC is located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Why It Matters

This filing provides routine disclosure for international companies like AstraZeneca, informing investors about their ongoing reporting status and corporate information.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign issuer and does not contain specific financial or operational news that would typically indicate a change in risk.

Key Players & Entities

  • AstraZeneca PLC (company) — Filer of the report
  • 0001104659-25-105425 (filing_id) — Accession number for the filing
  • 20251103 (date) — Filing date and period of report
  • 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (address) — Company's business and mail address
  • ZENECA GROUP PLC (company) — Former company name
  • 19930422 (date) — Date of name change from ZENECA GROUP PLC

FAQ

What type of report is AstraZeneca PLC filing?

AstraZeneca PLC is filing a Form 6-K, which is a Report of Foreign Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.

When was this Form 6-K filed?

This Form 6-K was filed on November 3, 2025.

What is AstraZeneca PLC's primary business address?

AstraZeneca PLC's business address is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Does AstraZeneca PLC file annual reports under Form 20-F or 40-F?

The filing indicates that AstraZeneca PLC files annual reports under cover of Form 20-F.

What was AstraZeneca PLC's former company name?

AstraZeneca PLC's former company name was ZENECA GROUP PLC, with a date of name change on April 22, 1993.

Filing Stats: 239 words · 1 min read · ~1 pages · Grade level 17.9 · Accepted 2025-11-03 12:36:37

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ASTRAZENECA PLC Date: November 3, 2025 By: /s/ Matthew Bowden Name: Matthew Bowden Title: Company Secretary

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.